Short to mid-term outcomes of hip arthroscopy for femoroacetabular impingement and labral tears in patients with diabetes.

Abstract

The purpose of this study is to report outcomes of patients with Diabetes Mellitus (DM) who underwent hip arthroscopy for femoroacetabular impingement (FAI) at short- to mid-term timepoints comparing these results to a control group of non-DM patients. Data were retrospectively analyzed for patients who underwent primary hip arthroscopy for FAI with a history of DM. Patients had completed pre- and postoperative patient-reported outcomes (PROs) at a minimum 2-year follow-up, including clinically important thresholds for hip arthroscopy, revision surgery, and conversion to arthroplasty. Subanalysis was conducted based on glycemic control. Patients were propensity matched to a control group of nondiabetic patients in a 1:3 ratio. A total of 116 patients were included, with 29 DM patients matched to 87 control patients. DM patients displayed significant improvements across all PROs and high patient satisfaction. No significant differences were observed in the sub-analysis. When compared to a control group, DM patients had lower preoperative PROs and reached similar postoperative scores. DM patients had significantly lower patient satisfaction (7.70 ± 2.43 compared to 8.63 ± 1.57 in the control group <i>P</i> < .05.) at the latest follow-up and had a higher relative risk for revision hip arthroscopy (<i>P</i> < .05). Hip arthroscopy for the treatment of FAI in DM patients resulted in significant short- to mid-term improvements in PROs, comparable to a matched control group. DM patients had an overall 2.63-fold increased relative risk of revision hip arthroscopy compared to non-DM patients, with a trend toward more uncontrolled DM patients undergoing revision hip arthroscopy. Perioperative diabetic control is recommended.